Although several molecular mechanisms contribute to tumor angiogenesis, the vascular endothelial growth factor (VEGF) pathway seems particularly important and has thus served as a prominent therapeutic target in cancer treatment [1,2]. This evidence concerns the gene VEGFA and neoplasm.